ARS Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
ARS Pharmaceuticals, Inc. has filed 520 SEC EDGAR filings since 12 Apr 2016

SEC filing history

Showing 51-75 of 520 matching filings.

Per page
25
Current page
3
4

4 filing

Filing date
22 Aug 2025
Reporting date
21 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Aug 2025
Reporting date
21 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Aug 2025
Reporting date
19 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39756

144 filing

Filing date
21 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39756

144 filing

Filing date
21 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39756

144 filing

Filing date
19 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-91894

SCHEDULE 13D/A filing

Filing date
01 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-91894

SCHEDULE 13D/A filing

Filing date
22 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jul 2025
Reporting date
01 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-91894

SCHEDULE 13D/A filing

Filing date
02 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Jul 2025
Reporting date
27 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39756

144 filing

Filing date
01 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Jun 2025
Reporting date
25 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Jun 2025
Reporting date
25 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Jun 2025
Reporting date
25 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Jun 2025
Reporting date
25 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Jun 2025
Reporting date
25 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Jun 2025
Reporting date
25 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Jun 2025
Reporting date
25 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Jun 2025
Reporting date
25 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Jun 2025
Reporting date
25 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .